Opportunities and barriers to translating the hibernation phenotype for neurocritical care
- PMID: 36779060
- PMCID: PMC9911456
- DOI: 10.3389/fneur.2023.1009718
Opportunities and barriers to translating the hibernation phenotype for neurocritical care
Abstract
Targeted temperature management (TTM) is standard of care for neonatal hypoxic ischemic encephalopathy (HIE). Prevention of fever, not excluding cooling core body temperature to 33°C, is standard of care for brain injury post cardiac arrest. Although TTM is beneficial, HIE and cardiac arrest still carry significant risk of death and severe disability. Mammalian hibernation is a gold standard of neuroprotective metabolic suppression, that if better understood might make TTM more accessible, improve efficacy of TTM and identify adjunctive therapies to protect and regenerate neurons after hypoxic ischemia brain injury. Hibernating species tolerate cerebral ischemia/reperfusion better than humans and better than other models of cerebral ischemia tolerance. Such tolerance limits risk of transitions into and out of hibernation torpor and suggests that a barrier to translate hibernation torpor may be human vulnerability to these transitions. At the same time, understanding how hibernating mammals protect their brains is an opportunity to identify adjunctive therapies for TTM. Here we summarize what is known about the hemodynamics of hibernation and how the hibernating brain resists injury to identify opportunities to translate these mechanisms for neurocritical care.
Keywords: NIRS; TTM; cerebral ischemia; ground squirrel; ischemia/reperfusion; neurocritical care; therapeutic hypothermia; torpor.
Copyright © 2023 Drew, Bhowmick, Laughlin, Goropashnaya, Tøien, Sugiura, Wong, Pourrezaei, Barati and Chen.
Conflict of interest statement
KD has a financial interest in Be Cool Pharmaceutics. KD and BL hold intellectual property for technology related to synthetic torpor. ZB has a financial interest in Barati Medical. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Bro-Jeppesen J, Annborn M, Hassager C, Wise MP, Pelosi P, Nielsen N, et al. Hemodynamics and vasopressor support during targeted temperature management at 33 degrees c versus 36 degrees c after out-of-hospital cardiac arrest: a post hoc study of the target temperature management trial*. Crit Care Med. (2015) 43:318–27. 10.1097/CCM.0000000000000691 - DOI - PubMed
